Coronal hypothalamic sections (16 µm) were cut on a cryostat and immediately stored at -80°C until hybridization. Specific oligos for AgRP, FAS and NPY detection were used (Table S2 ). These probes were 3'-end labeled with 35 S-αdATP using terminal deoxynucleotidyl transferase (Amersham Biosciences; Little Chalfont, UK). In situ hybridizations were performed as previously published (López et al., 2000; López et al., 2001; López et al., 2002; Seoane et al., 2003; García et al., 2003; López et al., 2004; Coll et al., 2005; López et al., 2005; López et al., 2006; Chakravarthy et al., 2007; López et al., 2007a; López et al., 2007b) .
35
S-αdATP using terminal deoxynucleotidyl transferase (Amersham Biosciences; Little Chalfont, UK). In situ hybridizations were performed as previously published (López et al., 2000; López et al., 2001; López et al., 2002; Seoane et al., 2003; García et al., 2003; López et al., 2004; Coll et al., 2005; López et al., 2005; López et al., 2006; Chakravarthy et al., 2007; López et al., 2007a; López et al., 2007b) .
Similar anatomical regions were analyzed using the rat brain atlas of Paxinos & Watson (Paxinos and Watson, 1986) . The slides from all experimental groups were exposed to the same autoradiographic film. All sections were scanned and the specific hybridization signal was quantified by densitometry using a digital imaging system (ImageJ 1.33, NIH) (López et al., 2000; López et al., 2001; López et al., 2002; Seoane et al., 2003; García et al., 2003; López et al., 2004; Coll et al., 2005; López et al., 2005; López et al., 2006; Chakravarthy et al., 2007; López et al., 2007a; López et al., 2007b) . The optical density of the hybridization signal was determined and subsequently corrected by the optical density of its adjacent background value. A rectangle, with the same dimensions in each case, was drawn enclosing the hybridization signal over each nucleus and over adjacent brain areas of each section (background). For the in situ analysis we used between 8 and 16 animals per experimental group (with a maximal of 21 animals in vehicle and ghrelin ICV 5 µg for 6 hours) from at least two independent experiments. We used between 16 and 20 sections for each animal (4-5 slides with four sections per slide). The mean of these 16-20 values was used as the densitometry value for each animal.
Immunohistochemistry
Rats were perfused through the ascending aorta with 150 ml 0.9% NaCl, followed by 500 ml of 4% formaldehyde in 100 mM phosphate buffer (PB), pH 7.4, under deep anaesthesia with ketamine-xylacine. Brains were removed and post-fixed in the same fixative for 12 hours at 4ºC and then transferred to PB for 1 hour. The brain pieces were cut 50 µm thick using a Vibratome® Series 1000.
Diaminobenzidine (DAB) immunohistochemistry was performed as described (Blanco et al., 2001; López et al., 2006 ) using a rabbit anti-FAS antibody (Abcam; Cambridge, UK) and EnVision TM rabbit (Dako, Glostrup, Denmark) as detection system. Sections were analyzed qualitatively with an Olympus light microscope and FAS-immunoreactivity (IR) in appropriate nuclei (ARC, PVH and VMH) was quantified. For each region, three to four adjacent sections were counted, and for each section both sides of the brain were counted. The average number of stained cells on both sides was used to represent the number of FAS-IR-positive cells in that section. Animals from each treatment group (n=5-6) were compared by using the mean number of stained cells in all sections counted in that nucleus (López et al., 2006) .
For GFP immunofluorescence free-floating sections were incubated overnight at 4ºC with rabbit anti-GFP antibody (Abcam; Cambridge, UK) diluted 1:1000 in PBS (100 mM phosphate buffer 0.65 M NaCl). After two washes (5 min each) in PBS, sections were incubated for 1h at room temperature with anti-rabbit F(ab') 2 fragment Alexa Fluor ® 488 (Molecular Probes; Eugene, OR) diluted 1:200 in PBS. Sections were mounted on poly-L-lysine-coated slides (Histobond, Paul Marienfeld GmbH & Co, Lauda-Königshofen, Germany) and coverslipped with aqueous mounting medium, immuno-fluor (ICN, Biomedicals; Aurora, OH). Negative controls were performed in sham non adenovirus-injected rats. On addition to GPF immunostaining, we checked the presence of direct GFP fluorescence in all the animals we analyzed by using in situ hybridization. In the animals used for western blot, we performed western blots against GFP ( Figure 4C ).
Double labeling
Rats brains were fixed by perfusion followed by immersion (12h) in 10% buffered formalin for 24 hours. Sections 50 µm thick were cut on a Vibratome ® Series 1000. Double immunofluorescence sequential protocol for GHS-R and FAS was performed as previously described (Blanco et al., 2001) . Sections were consecutively incubated in: 1) rabbit anti-FAS (Abcam, Cambridge, UK) dilution 1:500 overnight at room temperature; 2) anti-rabbit Cyanine 3 (Sigma, St. Louis, MO) 1:100 for 1 h; 3) goat anti-GHS-R or goat anti-BDNF (Santa Cruz Biotechnology, Inc; Santa Cruz CA, USA) dilution 1:50 or 1:100, respectively, overnight at room temperature; 4) anti-goat F(ab') 2 fragment Alexa Fluor ® 488 (Molecular Probes, Eugene, OR) 1:200 for 1 h. All dilutions were done in PBS; between steps sections were washed in PBS. Sections were mounted on poly-L-lysine-coated slides and coverslipped with aqueous mounting medium, immuno-fluor. Sections were observed and photographed by using a Provis AX70 microscope (Olympus Corp., Tokyo, Japan). We used 4-5 rats/group.
Fed Fast 24h
Ghrelin (ng/ml) 2.1 ± 0.2 3.7 ± 0.3 *** Leptin (ng/ml) 5.5 ± 0.4 0.9 ± 0.2 *** Figure S2 . Effect of compound C on different hypothalamic kinases (A) Western blot and (B) hypothalamic levels (±SEM) of the described proteins in vehicle or compound C ICV-treated rats. PHK is assessed by studying its substrate GP; TBK1 and IKKε are assessed by studying its substrate IRF-3. *: P<0.05 vs. vehicle; **: P<0.01 vs. vehicle. CaMKKα: Ca(2+)/calmodulin-dependent protein kinase kinase alpha; CaMKKβ: Ca(2+)/calmodulin-dependent protein kinase kinase beta; GP: glycogen phosphorylase; IKKε: inhibitory {kappa}B kinase {epsilon}; IRF-3: IFN regulatory factor-3; PHK: phosphorylase kinase; SRC: sarcoma kinase; TBK1: TANK-binding kinase 1. Figure S3 . Ghrelin inhibits FAS expression specifically in the VMH but not in other brain areas Food intake (±SEM) after (A) ICV (B) IP ghrelin injections at the described doses (IP: 10 nmol). FAS mRNA levels (±SEM) in the described brain areas of (C) vehicle and ghrelin ICV-treated rats (same doses than Figure S3A) 
